Information on passing on some prescription drugs handled by this hospital to the new company

With the spin-off of MSD (Merck in the US and Canada), the products handled by the company will be inherited by Organon. After the product succession date from MSD Co., Ltd. to Organon Co., Ltd., the successor products will be shipped as soon as the current products are sold out. There will be a period in which products with the names of both companies are mixed for a while, but please note that there is no difference in the content of prescription drugs.

Target product and inheritance date

Our hospital: Prescription drugs handled by Women's Healthcare Online

Inheritance date Drug name
2021/09/01 Maveron 21 and 28

Formulation photo

 

A company that inherits products

Our hospital: Women's Healthcare Items other than prescription drugs handled online

Inheritance date Drug name
2021/05/01 Singular tablets 5 mg and 10 mg
Singular OD Tablets 10mg
Singular fine granules 4mg
Singular Chewable Tablets 5mg
2021/06/01 Neurotan Tablets 25mg, 50mg and 100mg
Preminent Combination Tablets LD and HD
Remeron tablets 15 mg and 30 mg
2021/07/01 Lipobus locks 5, 10 and 20
Propecia Tablets 0.2mg and 1mg
(Target: AGA androgenetic alopecia. Handled at Shinjuku / Shibuya West Clinic )
Renibase 2.5, 5 and 10
2021/08/01 Fosamac Tablets 35mg
Azmanex Twist Heller 100μg
2021/09/01 Resulin Tablets 25 and 50
Ganirest Subcutaneous Injection 0.25mg Syringe
Maveron 21 and 28
(low-dose pills, our clinic: women's healthcare online )
Menesit Combination Tablets 100 and 250
2021/10/01 Zetia Tablets 10mg
Attozette Combination Tablets LD and HD
Ross-Zet Combination Tablets LD and HD
Tetramid 10 mg and 30 mg